Info

Viral Therapeutics, Inc. has operated as a developer and manufacturer of recombinant proteins since 1995. With its strategy to license and develop technology, as well as a highly talented and experienced staff, VTI became a leading supplier of recombinant human proteins for research and diagnostic use. From these competencies, VTI continues to build a proprietary product portfolio for the biotechnology and pharmaceutical industries. Employing a revenue-based strategy, coupled with licensing and strategic partnerships, we have built a biotechnology company that provides support for over 55 clients and partners worldwide. VTI has either licensed or owned over 110 patents and patent applications.